000163838 001__ 163838
000163838 005__ 20240229123157.0
000163838 0247_ $$2doi$$a10.3390/cancers12102770
000163838 0247_ $$2pmid$$apmid:32992489
000163838 0247_ $$2altmetric$$aaltmetric:91778363
000163838 037__ $$aDKFZ-2020-02078
000163838 041__ $$aeng
000163838 082__ $$a610
000163838 1001_ $$0P:(DE-He78)98a8f1a22ffc460364a8a34499118103$$aZheng, Guoqiao$$b0$$eFirst author
000163838 245__ $$aCancer Predisposition Genes in Cancer-Free Families.
000163838 260__ $$aBasel$$bMDPI$$c2020
000163838 3367_ $$2DRIVER$$aarticle
000163838 3367_ $$2DataCite$$aOutput Types/Journal article
000163838 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1683891772_20083
000163838 3367_ $$2BibTeX$$aARTICLE
000163838 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163838 3367_ $$00$$2EndNote$$aJournal Article
000163838 500__ $$a#EA:C050#LA:B062#LA:C050#LA:C020#
000163838 520__ $$aFamilial clustering, twin concordance, and identification of high- and low-penetrance cancer predisposition variants support the idea that there are families that are at a high to moderate excess risk of cancer. To what extent there may be families that are protected from cancer is unknown. We wanted to test genetically whether cancer-free families share fewer breast, colorectal, and prostate cancer risk alleles than the population at large. We addressed this question by whole-genome sequencing (WGS) of 51 elderly cancer-free individuals whose numerous (ca. 1000) family members were found to be cancer-free ('cancer-free families', CFFs) based on face-to-face interviews. The average coverage of the 51 samples in the WGS was 42x. We compared cancer risk allele frequencies in cancer-free individuals with those in the general population available in public databases. The CFF members had fewer loss-of-function variants in suggested cancer predisposition genes compared to the ExAC data, and for high-risk cancer predisposition genes, no pathogenic variants were found in CFFs. For common low-penetrance breast, colorectal, and prostate cancer risk alleles, the results were not conclusive. The results suggest that, in line with twin and family studies, random environmental causes are so dominant that a clear demarcation of cancer-free populations using genetic data may not be feasible.
000163838 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000163838 588__ $$aDataset connected to CrossRef, PubMed,
000163838 7001_ $$0P:(DE-He78)00b54a2735b6724e523a14642acac422$$aCatalano, Calogerina$$b1$$eFirst author
000163838 7001_ $$0P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc$$aBandapalli, Obul Reddy$$b2
000163838 7001_ $$aParamasivam, Nagarajan$$b3
000163838 7001_ $$0P:(DE-He78)9918be87133a5ff93034e03087506c3c$$aChattopadhyay, Subhayan$$b4
000163838 7001_ $$0P:(DE-He78)f2a782242acf94a3114d75c45dc75b37$$aSchlesner, Matthias$$b5
000163838 7001_ $$aSijmons, Rolf$$b6
000163838 7001_ $$aHemminki, Akseli$$b7
000163838 7001_ $$aDymerska, Dagmara$$b8
000163838 7001_ $$aLubinski, Jan$$b9
000163838 7001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b10$$eLast author
000163838 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b11$$eLast author
000163838 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers12102770$$gVol. 12, no. 10, p. 2770 -$$n10$$p2770$$tCancers$$v12$$x2072-6694$$y2020
000163838 909CO $$ooai:inrepo02.dkfz.de:163838$$pVDB
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)98a8f1a22ffc460364a8a34499118103$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)00b54a2735b6724e523a14642acac422$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9918be87133a5ff93034e03087506c3c$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f2a782242acf94a3114d75c45dc75b37$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000163838 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000163838 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000163838 9141_ $$y2020
000163838 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2018$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2019-12-21
000163838 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2018$$d2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2019-12-21
000163838 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2019-12-21
000163838 9201_ $$0I:(DE-He78)C050-20160331$$kC050$$lMolekular-Genetische Epidemiologie$$x0
000163838 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000163838 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000163838 9201_ $$0I:(DE-He78)B240-20160331$$kB240$$lBioinformatik und Omics Data Analytics$$x3
000163838 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x4
000163838 980__ $$ajournal
000163838 980__ $$aVDB
000163838 980__ $$aI:(DE-He78)C050-20160331
000163838 980__ $$aI:(DE-He78)B062-20160331
000163838 980__ $$aI:(DE-He78)HD01-20160331
000163838 980__ $$aI:(DE-He78)B240-20160331
000163838 980__ $$aI:(DE-He78)C020-20160331
000163838 980__ $$aUNRESTRICTED